Patent · US Expired

4,5,6,7-Tetrahydro-thieno[2,3-c]-and [3,2-c]-pyridines, and therapeutic compositions containing the same

US4147787A · kind A · utility

8Cited by
3References
3Claims
0Family size

Assignee

Inventor

Key dates

Filing dateDec 27, 1977
Grant dateApr 3, 1979
Priority date
Expiry dateDec 27, 1997

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P7/02
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

This invention relates to 4,5,6,7-tetrahydro-thieno[2,3-c]- and [3,2-c]-pyridines having the formulae: ##STR1## in which R.sup.1 is selected from hydrogen and halogen; R.sup.2 is selected from hydrogen and hydroxy; R.sup.3 and R.sup.4, which may be the same or different, are each selected from hydrogen, C.sub.1-6 alkyl, phenylalkyl having 1-6 carbon atoms in the alkyl moiety, and phenyl-C.sub.1-6 alkyl substituted on the phenyl nucleus with at least a substituent selected from halogen, C.sub.1-6 alkyl, C.sub.1-6 alkoxy, hydroxy, nitro, cyano and trifluoromethyl; and their acid addition salts. Said derivatives possess therapeutically useful anti-sludge, anti-thrombosis and blood-platelet aggregation inhibiting properties.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.